Citation Impact
Citing Papers
Chylomicrons promote intestinal absorption of lipopolysaccharides
2008
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
2000
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Hepatic encephalopathy
2001
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Noninvasive Pressure Support Ventilation in Patients With Acute Respiratory Failure
1993
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Controlled release of transforming growth factor ?1 from biodegradable polymer microparticles
2000
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Distal Splenorenal Shunt Versus Endoscopic Sclerotherapy in the Prevention of Variceal Rebleeding First Stage of a Randomized, Controlled Trial
1990
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
1995 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN
1987 Standout
A proposed model for the assembly of chylomicrons
2000
Rifaximin Treatment in Hepatic Encephalopathy
2010
The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption
2002
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
COPII-coated vesicles: flexible enough for large cargo?
2005 StandoutNobel
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Endoscopic Sclerotherapy as Compared with Endoscopic Ligation for Bleeding Esophageal Varices
1992 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Localization and Regulation of the Putative Membrane Fatty‐Acid Transporter (FAT) in the Small Intestine
1996
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Controlled Drug Delivery by Biodegradable Poly(Ester) Devices: Different Preparative Approaches
1998
Noninvasive Pressure Support Ventilation in Patients With Acute Respiratory Failure
1995
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
2002 Standout
Atherosclerosis
2001 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Wine, alcohol, platelets, and the French paradox for coronary heart disease
1992 Standout
Effects of ethanol on lipid metabolism.
1979
Fluorine in medicinal chemistry
2007 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
ENDOSCOPY IN GASTROINTESTINAL BLEEDING
1974 Standout
Micro/Nano Encapsulation via Electrified Coaxial Liquid Jets
2002 StandoutScience
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles
2011 Standout
Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions.
1989
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Atherosclerosis: Basic Mechanisms
1995 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
1994
New developments in the incretin concept
1985
COPII-mediated vesicle formation at a glance
2010 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Effect of dietary n-3 fatty acids on HMG-CoA reductase and ACAT activities in liver and intestine of the rabbit.
1986
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Controlled Ring-Opening Polymerization of Lactide and Glycolide
2004 Standout
Upper Gastrointestinal Bleeding
1972
In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461
1997
Metal–Organic Frameworks in Biomedicine
2011 Standout
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of J.B. Rodgers being referenced
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
1977
The Evaluation of Lyophilized Polymer Matrices for Administering Recombinant Human Bone Morphogenetic Protein-2
1996
Two Lyophilized Polymer Matrix Recombinant Human Bone Morphogenetic Protein-2 Carriers in Rabbit Calvarial Defects
1998
Animal models for the study of bone loss after cessation of ovarian function
1993
Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy
1977
The effect of acute ethanol treatment on lipid-reesterifying enzymes of the rat small bowel
1975
Adaptive changes of the rat small intestine in response to a high fat diet
1972
Effects of saturated and unsaturated fats given with and without dietary cholesterol on hepatic cholesterol synthesis and hepatic lipid metabolism
1978
Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat
1980
Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat
1981
THE MANAGEMENT OF ACUTE MASSIVE GASTRO-DUODENAL HEMORRHAGE.
1964
Absorption and excretion of the hydrophobic surfactant, 14C-poloxalene 2930, in the rat.
1984
Poloxalene 2930, a hydrophobic surfactant that prevents atherosclerosis, alters composition of rabbit lipoproteins
1985
Maximal lymphatic triglyceride transport rate from the rat small intestine
1982